|Bid||137.27 x 1000|
|Ask||136.95 x 900|
|Day's range||131.28 - 138.49|
|52-week range||112.47 - 179.57|
|Beta (5Y monthly)||1.00|
|PE ratio (TTM)||35.06|
|Forward dividend & yield||0.84 (0.61%)|
|Ex-dividend date||03 Jan 2022|
|1y target est||N/A|
SANTA CLARA, Calif., January 24, 2022--Agilent Technologies Inc. (NYSE: A) today announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools. With enhanced performance, more robust and efficient workflows, and an optimized user experience, the XF Pro enables operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fat
SANTA CLARA, Calif., January 13, 2022--Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal year 2022 financial results after the stock market closes on Tuesday, Feb. 22. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
SANTA CLARA, Calif., January 10, 2022--Agilent Technologies Inc. (NYSE: A) today announced that Professor Jason Kovacic has been selected to receive a prestigious Agilent Thought Leader Award. Professor Kovacic is being recognized for his influential research on cardiovascular disease—specifically the pathobiology of vascular diseases, coronary artery disease, fibromuscular dysplasia and spontaneous coronary artery dissection.